BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22038135)

  • 1. [Diagnosis and differential diagnosis of cervical adenocarcinoma].
    Löning T; Riethdorf L; Köbel M
    Pathologe; 2011 Nov; 32(6):505-13. PubMed ID: 22038135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Precancerous lesions of the uterine cervix: morphology and molecular pathology].
    Horn LC; Klostermann K
    Pathologe; 2011 Nov; 32 Suppl 2():242-54. PubMed ID: 21909794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive adenocarcinoma and related tumors of the uterine cervix.
    Young RH; Scully RE
    Semin Diagn Pathol; 1990 Aug; 7(3):205-27. PubMed ID: 2218147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
    Park KJ
    Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HPV-induced diseases of the female genital tract].
    Schmidt D
    Pathologe; 2011 Nov; 32(6):449-50. PubMed ID: 22038131
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.
    Young RH; Clement PB
    Histopathology; 2002 Sep; 41(3):185-207. PubMed ID: 12207781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocervical glandular lesions: controversial aspects and ancillary techniques.
    McCluggage WG
    J Clin Pathol; 2003 Mar; 56(3):164-73. PubMed ID: 12610091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors.
    Pirog EC
    Arch Pathol Lab Med; 2017 Dec; 141(12):1653-1667. PubMed ID: 28644686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
    Mikami Y; McCluggage WG
    Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cervical cancer : Update on morphology].
    Horn LC; Brambs CE; Handzel R; Lax S; Sändig I; Schmidt D; Schierle K
    Pathologe; 2016 Nov; 37(6):542-548. PubMed ID: 27766382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on gynecopathology].
    Schmidt D
    Pathologe; 2013 Feb; 34(1):25-33. PubMed ID: 23263439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular diagnosis of HPV infections].
    Wentzensen N
    Pathologe; 2011 Nov; 32(6):461-6. PubMed ID: 21845360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of cervical glandular neoplasia and issues in differential diagnosis.
    Loureiro J; Oliva E
    Arch Pathol Lab Med; 2014 Apr; 138(4):453-83. PubMed ID: 24678677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
    Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
    Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
    Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
    Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
    Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.